- Home
- PGC vs HQL Comparison
PGC vs HQL Comparison
Compare PGC & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGC
- HQL
- Stock Information
- Founded
- PGC 1921
- HQL 1992
- Country
- PGC United States
- HQL United States
- Employees
- PGC N/A
- HQL N/A
- Industry
- PGC Commercial Banks
- HQL Investment Managers
- Sector
- PGC Finance
- HQL Finance
- Exchange
- PGC Nasdaq
- HQL Nasdaq
- Market Cap
- PGC 475.7M
- HQL 377.2M
- IPO Year
- PGC N/A
- HQL N/A
- Fundamental
- Price
- PGC $36.37
- HQL $13.78
- Analyst Decision
- PGC Buy
- HQL
- Analyst Count
- PGC 1
- HQL 0
- Target Price
- PGC $32.00
- HQL N/A
- AVG Volume (30 Days)
- PGC 139.9K
- HQL 120.9K
- Earning Date
- PGC 10-22-2024
- HQL 01-01-0001
- Dividend Yield
- PGC 0.55%
- HQL 11.56%
- EPS Growth
- PGC N/A
- HQL N/A
- EPS
- PGC 1.82
- HQL 0.79
- Revenue
- PGC $209,728,000.00
- HQL N/A
- Revenue This Year
- PGC N/A
- HQL N/A
- Revenue Next Year
- PGC $20.06
- HQL N/A
- P/E Ratio
- PGC $20.00
- HQL $17.08
- Revenue Growth
- PGC N/A
- HQL N/A
- 52 Week Low
- PGC $20.30
- HQL $11.34
- 52 Week High
- PGC $37.88
- HQL $14.37
- Technical
- Relative Strength Index (RSI)
- PGC 62.84
- HQL 33.14
- Support Level
- PGC $35.32
- HQL $13.68
- Resistance Level
- PGC $37.07
- HQL $14.37
- Average True Range (ATR)
- PGC 1.41
- HQL 0.27
- MACD
- PGC -0.20
- HQL -0.10
- Stochastic Oscillator
- PGC 75.68
- HQL 5.92
About PGC Peapack-Gladstone Financial Corporation
Peapack Gladstone Financial Corp provides banking services. It operates through two segments namely Banking, which involves the delivery of loans and deposits, and Peapack Private Division which includes asset management services. The banking segment includes commercial real estate, multifamily, residential and consumer lending, deposit generation, and internet banking services. Peapack Private includes asset management services for individuals and institutions; personal trust services, administrator, custodian and guardians, and other financial planning and advisory services.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.